本页面由Tiger Trade Technology Pte. Ltd.提供服务

Arcus Biosciences Inc.

22.11
-0.1000-0.45%
盘后21.63-0.4757-2.15%19:43 EST
成交量:65.44万
成交额:1,440.91万
市值:27.71亿
市盈率:-6.72
高:22.36
开:21.79
低:21.34
收:22.21
52周最高:26.40
52周最低:6.50
股本:1.25亿
流通股本:8,865.18万
量比:0.39
换手率:0.74%
股息:- -
股息率:- -
每股收益(TTM):-3.2900
每股收益(LYR):-3.2900
净资产收益率:-63.26%
总资产收益率:-21.08%
市净率:4.39
市盈率(LYR):-6.72

数据加载中...

2026/02/25

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/25

重要事件披露

Form 8-K - Current report
2026/01/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/18

重要事件披露

Form 8-K - Current report
2025/12/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/12

重要事件披露

Form 8-K - Current report
2025/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/03

重要事件披露

Form 8-K - Current report